Journey from Researcher to Consultant in Cell and Gene Therapy

This chapter chronicles the speaker's transition from a researcher in cell and gene therapies to their current consulting role at Deloitte. They provide insights into the industry's evolution, the role of interdisciplinary teams, and their focus on enhancing manufacturing and supply chain processes to deliver innovative treatments.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Get the app